Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial †
Titel:
Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial †
Auteur:
Eigentler, T.K. Gutzmer, R. Hauschild, A. Heinzerling, L. Schadendorf, D. Nashan, D. Hölzle, E. Kiecker, F. Becker, J. Sunderkötter, C. Moll, I. Richtig, E. Pönitzsch, I. Pehamberger, H. Kaufmann, R. Pföhler, C. Vogt, T. Berking, C. Praxmarer, M. Garbe, C.